Large pericardial effusions due to systemic lupus erythematosus: A report of eight cases

Lupus

Volumn 14, Issue 6, 2005, Pages 450-457

  Weich, H S V H ^a   Burgess, L J ^a,b   Reuter, H ^a   Brice, E A ^a   Doubell, A F ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b TREAD Research   (South Africa)

Author keywords

Cardiac tamponade; Pancarditis; Pericardial effusions; Pericarditis; Systemic lupus erythematosus (SLE)

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTRICTIVE PERICARDITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEART TAMPONADE; HUMAN; LABORATORY TEST; LIBMAN SACKS ENDOCARDITIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; PROGNOSIS; RAYNAUD PHENOMENON; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; DRAINAGE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PERICARDIAL EFFUSION; PREDNISONE;

EID: 21844452192     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2131oa     Document Type: Article

References (33)

1. Chang RW. Cardiac manifestations of systemic lupus erythematosus. Clin Rheum Dis 1982; 8: 197-206.
2. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971; 50: 85-95.
3. Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. JAMA 1964; 190: 104-111.
4. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985; 110: 1257-1265.
5. Koch CA. Cardiac tamponade in SLE. Lupus 1999; 8: 250 (letter).
6. Bridgen W, Bywaters EG, Lesoff MH, Ross IP. The heart in systemic lupus erythematosus. Br Heart J 1960; 22: 1-16.
7. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
8. Castier MB, Albuquerque EM, Menezes ME, Klumb E, Albanesi Filho FM. Cardiac tamponade in systemic lupus erythematosus: report of four cases. Arq Bras Cardiol 2000; 75: 446-448.
9. Kahl LE. The spectrum of pericardial tamponade in systemic lupus erythematosus: Report of ten patients. Arthritis Rheum 1992; 35: 1343-1349.
10. Carroll N, Barrett JA. Systemic lupus erythematosus presenting with cardiac tamponade. Br Heart J 1984; 51: 452-453.
11. Ehrenfeld M, Asman A, Shpilberg O, Samra Y. Cardiac tamponade as the presenting manifestation of systemic lupus erythematosus. Am J Med 1989; 86: 626-627.
12. Lee IH, Yang SC, Kim TH et al. Cardiac tamponade as an initial manifestation of systemic lupus erythematosus-single case report. J Korean Med Sci 1997; 12: 75-77.
13. Lerer RJ. Cardiac tamponade as an initial finding in systemic lupus erythematosus. Am J Dis Child 1972; 124: 436-437.
14. Manresa JM, Gutierrez L, Viedma P, Alfani O. Cardiac tamponade as a clinical symptom of systemic lupus erythematosus. Rev Esp Cardiol 1997; 50: 600-602.
15. Nour-Eddine M, Bennis A, Soulami S, Chraibi N. Cardiac tamponade disclosing systemic lupus erythematosus. Ann Cardiol Angiol (Paris) 1996; 45: 71-73.
16. Reiner JS, Furie RA. Cardiac tamponade as an initial manifestation of systemic lupus erythematosus. J Rheumatol 1989; 16: 1127-1129.
17. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924; 33: 701-737.
18. Burgess LJ, Reuter H, Taljaard JJ, Doubell AF. Role of biochemical tests in the diagnosis of large pericardial effusions. Chest 2002; 121: 495-499.
19. Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF. The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest 2002; 122: 900-905.
20. Snaith ML, Isenberg DA. Systemic lupus erythematosus and related disorders. In: Weatherall DJ, Ledingham JGG, Warrell DA eds. Oxford textbook of medicine. Oxford: Oxford University Press, 1996: 3020-3027; 3188.
21. Rudra T, Evans PA, O'Brien EN. Systemic lupus erythematosus presenting with cardiac tamponade due to a hemorrhagic pericardial effusion. Postgrad Med J 1987; 63: 567-568.
22. Siddiqui MA, Khan IA. Isoniazid-induced lupus erythematosus presenting with cardiac tamponade. Am J Ther 2002; 9: 163-165.
23. Carey RM, Coleman M, Feder A. Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome. Am J Med 1973; 54: 84-87.
24. Kong TQ, Kellum RE, Haserick JR. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus. Circulation 1962; XXVI: 7-11.
25. Singh S, Wann LS, Schuchard GH et al. Right ventricular and right atrial collapse in patients with cardiac tamponade - a combined echocardiographic and hemodynamic study. Circulation 1984; 70: 966-971.
26. Bijl M, Brouwer J, Kallenberg GG. Cardiac abnormalities in SLE: pancarditis. Lupus 2000; 9: 236-240.
27. Strauer B, Brune I, Schenk H, Knoll D, Perings E. Lupus cardiomyopathy: cardiac mechanics, hemodynamics and coronary blood flow in uncomplicated systemic lupus erythematosus. Am Heart J 1972; 92: 715-722.
28. Borenstein DG, Fye WB, Arnett FC, Stevens MB. The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med 1978; 89: 619-624.
29. Gomez P, Oakey CM. Association between cardiac abnormalities and raised anticardiolipin antibodies in systemic lupus erythematosus. Postgrad Med J 1988; 64: 723 (abstract).
30. Linares LF, Gomez-Reino JJ, Carreira PE, Morillas L, Ibero I. C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE). Clin Rheumatol 1986; 5: 66-69.
31. Bertouch JV, Roberts-Thompson PJ, Feng PH, Bradley J. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus. Ann Rheum Dis 1983; 42: 655-658.
32. Manzi S, Rairie JE, Carpenter AB et al. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. Arthritis Rheum 1996; 39: 1178-1188.
33. Ho A, Barr SG, Magder LS, Petri M. A decrease in complement is associated with increased renal and hematological activity in patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2350-2357.